The potential acquisition of Syqe Medical by Phillip Morris represents a significant strategic move for the tobacco giant, signaling its entry into the flourishing marijuana industry. With an initial investment of $130 million to support Syqe’s FDA approval process, followed by a possible $650 million acquisition, this deal can potentially make Syqe one of the largest cannabis companies globally. Moreover, Syqe’s innovative inhaler, utilizing raw cannabis inflorescence, could secure FDA approval, positioning the company as a trailblazer in the medical cannabis sector.
As the movement for marijuana legalization gains momentum across the United States, a significant barrier…
Conventional treatments prescribed to treat autoimmune conditions are focused on taming inflammation; these usually include…
Discover deals like daily $10 eighths for the holiday weekend and beyond at Giving Tree…
Verilife Non-Medical Cannabis is now available in Ohio. Open to customers 21+ with a valid…
At Verilife, there's always a stocked selection of top products & new favorites. Find the…
At Verilife, there's always a stocked selection of top products & new favorites. Find the…